von Depka M - Search Results

1

Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.

Tacke F, Schöffski P, Trautwein C, Manns MP, Ganser A, von Depka M. Tacke F, et al. Among authors: von depka m. Blood Coagul Fibrinolysis. 2001 Oct;12(7):539-45. doi: 10.1097/00001721-200110000-00005. Blood Coagul Fibrinolysis. 2001. PMID: 11685041

2

Plasma P-selectin levels are elevated in patients with chronic liver disease.

Tacke F, Schöffski P, Trautwein C, Luedde T, Ganser A, Manns MP, von Depka M. Tacke F, et al. Among authors: von depka m. Blood Coagul Fibrinolysis. 2003 Jun;14(4):319-25. doi: 10.1097/00001721-200306000-00001. Blood Coagul Fibrinolysis. 2003. PMID: 12945872

3

Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.

Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Tacke F, et al. Among authors: von depka m. Liver Int. 2006 Mar;26(2):173-81. doi: 10.1111/j.1478-3231.2005.01205.x. Liver Int. 2006. PMID: 16448455

4

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.

von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, Ganser A, Ehrenforth S. von Depka M, et al. Blood. 2000 Nov 15;96(10):3364-8. Blood. 2000. PMID: 11071628 Free article.

5

Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophilia.

von Depka M, Czwalinna A, Eisert R, Wermes C, Scharrer I, Ganser A, Ehrenforth S. von Depka M, et al. Thromb Haemost. 2001 Dec;86(6):1360-2. Thromb Haemost. 2001. PMID: 11776299

6

The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism.

von Depka M, Czwalinna A, Wermes C, Eisert R, Scharrer I, Ganser A, Ehrenforth S. von Depka M, et al. Thromb Haemost. 2003 May;89(5):847-52. Thromb Haemost. 2003. PMID: 12719783

7

Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.

Benten D, Widjaja A, von Depka M, Flemming P, Trautwein C, Böker K, Vogel A, Rosenau J, Manns MP. Benten D, et al. Among authors: von depka m. Z Gastroenterol. 2001 Oct;39(10):837-40. doi: 10.1055/s-2001-17862. Z Gastroenterol. 2001. PMID: 11605152

8

Factor VIII inhibitor-tests could be less sensitive than supposed.

Barthels M, Kraus M, Bohn U, Liese B, von Depka M, Eisert R, Ganser A. Barthels M, et al. Among authors: von depka m. Vox Sang. 1999;77 Suppl 1:87-9. doi: 10.1159/000056725. Vox Sang. 1999. PMID: 10529697 No abstract available.

9

Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.

Tiede A, Eder M, von Depka M, Battmer K, Luther S, Kiem HP, Ganser A, Scherr M. Tiede A, et al. Among authors: von depka m. Gene Ther. 2003 Oct;10(22):1917-25. doi: 10.1038/sj.gt.3302093. Gene Ther. 2003. PMID: 14502221

10

The use of recombinant-activated factor VII in von Willebrand disease: a case series.

von Depka M, Hassan M, Blatnŷ J, Smejkal P, Vdovin V. von Depka M, et al. Blood Coagul Fibrinolysis. 2006 Jun;17(4):311-6. doi: 10.1097/01.mbc.0000224852.42625.0d. Blood Coagul Fibrinolysis. 2006. PMID: 16651875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters